Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

Prognostic Value of Volumetric and Textural Parameters measured by Pretreatment F-18 FDG PET/CT in Patients with Renal Cell Carcinoma

Jae Pil Hwang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1431;
Jae Pil Hwang
1Nuclear Medicine, Soonchunhyang, Seoul, Korea (the Republic of)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1431

Objectives The aim of this retrospective study was to determine whether volumetric and textural parameters assessed by pretreatment F-18 FDG PET/CT provides prognostic information independent of established prognostic factors in patients with renal cell carcinoma

Methods I reviewed retrospectively the medical records of 24 patients (men 15, women 9, mean age 64.8±12.5 years) with pathologic proven clear cell renal cell carcinoma. They underwent F-18 FDG PET/CT as part of a pretreatment workup from Februry 2007 to July 2012. For the analysis, patients were classified by age, sex, tumor size, nuclear grade, stage by AJCC, maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), total lesion glycolysis (TLG) and coefficient of variation (COV). The relationship between volumetric, textural parameters and survival was analyzed using the Kaplan-Meier with log-Rank test and Cox’s proportional-hazard regression methods.

Results Median survival for all 24 study subjects was 551 days and median SUVmax was 3.75 (range: 2-15.6). Patients with SUVmax of ≤3.75 survived significantly longer than patients with SUVmax of >3.75 ( Median 1572 vs. 360 days, P = 0.005). High MTV, TLG and COV also showed a poor overall survival (OS) than that of the lower parameter group. In univariate analysis the OS was found to be significantly related to age (P = 0.014), stage (P = 0.001), tumor size (P = 0.038), SUVmax (P = 0.004), MTV (P = 0.012), TLG (P = 0.001) and COV (P = 0.006). Multivariate analysis study revealed that the patients with higher SUVmax (P = 0.041, CI = 1.08 to 33.47, HR = 6.01), TLG (P = 0.003, CI = 2.93 to 252.43, HR = 27.19) and COV (P = 0.035, CI = 1.21 to 137.07, HR = 12.88) showed worse OS.

Conclusions SUVmax, TLG and COV derived from pretreatment F-18 FDG PET/CT contribute independent prognostic information on overall survival in patients with renal cell carcinoma.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Value of Volumetric and Textural Parameters measured by Pretreatment F-18 FDG PET/CT in Patients with Renal Cell Carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prognostic Value of Volumetric and Textural Parameters measured by Pretreatment F-18 FDG PET/CT in Patients with Renal Cell Carcinoma
Jae Pil Hwang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1431;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prognostic Value of Volumetric and Textural Parameters measured by Pretreatment F-18 FDG PET/CT in Patients with Renal Cell Carcinoma
Jae Pil Hwang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1431;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • Prognostic value of textural features of pretreatment 18F-FDG PET/CT in patients with nasal NK/T-cell lymphoma
  • The value of anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT in the diagnosis of recurrent prostate carcinoma: a meta-analysis
  • A prospective trial for the evaluation of esophageal cancer patients: FDG PET/CT vs. c.e.CT vs. FDG PET/c.e.CT
Show more Oncology: Clinical Diagnosis

MTA I: Prostate/GU Posters

  • Radiographic and laboratory assessment of bone metastases in castration-resistant prostate cancer patients undergoing Radium-223 dichloride therapy
  • A pilot study of 18F-DCFBC PET/CT imaging for tumor detection in prostate cancer patients with biochemical relapse after definitive treatment
  • Clinical utility of 18F-fluorocholine positron-emission tomography/computed tomography in initial staging & recurrence evaluation and its comparison with conventional imaging in patients with prostate cancer
Show more MTA I: Prostate/GU Posters

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire